| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5201730
Max Phase: Preclinical
Molecular Formula: C9H5BrClN3
Molecular Weight: 270.52
Associated Items:
Representations
Canonical SMILES: N#CCc1n[nH]c2cc(Cl)c(Br)cc12
Standard InChI: InChI=1S/C9H5BrClN3/c10-6-3-5-8(1-2-12)13-14-9(5)4-7(6)11/h3-4H,1H2,(H,13,14)
Standard InChI Key: FAGVHGZPQSWXCE-UHFFFAOYSA-N
Associated Targets(Human)
Casein kinase II alpha 3512 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 270.52 | Molecular Weight (Monoisotopic): 268.9355 | AlogP: 3.04 | #Rotatable Bonds: 1 |
| Polar Surface Area: 52.47 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.16 | CX Basic pKa: 1.13 | CX LogP: 2.75 | CX LogD: 2.75 |
| Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.87 | Np Likeness Score: -1.46 |
References
| 1. Brear P, De Fusco C, Atkinson EL, Iegre J, Francis-Newton NJ, Venkitaraman AR, Hyvönen M, Spring DR.. (2022) A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action., 13 (11.0): [PMID:36426237] [10.1039/d2md00161f] |
Source
Source(1):